Raytheon Technologies: a safe stock for an unsafe world
Defence spending is set to soar – that should be good news for aerospace heavyweight Raytheon Technologies.


Russia’s invasion of Ukraine has alerted democracies to the dangers of dictators with expansionist ambitions. The results will include strengthening of protective alliances and increased spending on defence. Germany, which has long undershot the Nato target of 2% GDP on defence, is now preparing to exceed that. Japan, which is conscious of China’s threats to invade democratic Taiwan and the South China Sea islands, has set a record defence budget for 2022. Australia is increasing its defence force by one-third.
Defence companies are thus likely to see sustained growth in orders. I recommended Lockheed Martin, the world’s largest defence company, in June 2020 (up around 22% since) and I am now recommending the world’s second-largest defence company – Raytheon Technologies (NYSE: RTX), which was formed by the merger of Raytheon and United Technologies in April 2020.
A wide range of products
Defence accounts for 65% of Raytheon’s sales, and this is likely to increase.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The group has four divisions: Pratt & Whitney produces commercial and military aero-engines. Key products include engines for the Airbus A320neo and A220 airliners, the F-35 and F-16 fighters, Apache helicopters and research on high-speed military engines.
Missiles & Defence makes the Patriot anti-missile systems (the world’s primary land-based system), naval missiles, hypersonic missiles, space sensors to detect missile launches, radars, and command and control systems.
Collins Aerospace makes aerospace avionics, structures and systems for Airbus, Boeing, Lockheed, Embraer and Dassault and for US submarines and destroyers.
Intelligence & Space, which again serves both military and commercial customers, covers airspace modernisation (surveillance, navigation, landing systems), battle management (command and control, land and satellite surveillance, electronic warfare planning and management) and hardening information systems against cyberattacks.
Developing new technologies
Raytheon’s research and development is focusing on areas including cyber-hardened connected systems (both commercial and battlespace), autonomy and artificial intelligence (unmanned aircraft, autonomous and semi-autonomous operations), propulsion (more sustainable commercial engines, next-generation military aircraft, hypersonics) and precision sensing and effects (space sensing, missiles and missile defence, directed energy weapons, electronic warfare). There are usually over 300 new ideas under assessment, with some gaining defence or commercial contracts.
Recent wins include a contract from the US Missile Defence Agency to develop and test the first interceptor to defeat hypersonic missile threats from Russia and China; an electro-optical system giving F-35 pilots an unprecedented 360-degree situational awareness and survivability; a joint Lockheed/Raytheon contract to build an Australian missile factory to counter threats from China; and a US Department of Energy contract to develop hydrogen propulsion technology for zero in-flight CO2 emissions, up to 80% reduction in NOx emissions and up to 35% reduction in fuel consumption.
Raytheon has a wide moat against competition based on extensive engineering know-how and close relationships with defence procurement agencies. Its products have high switching costs: long-term defence contracts typically have upgrade programmes to extend products’ lives, with substantial after-market sales. Investors get a company in a very strong position, trading on attractive valuations (see below) and with the prospect of upwards earnings revisions for the coming years if further orders come in as defence spending increases around the world.
Raytheon Technologies: a behemoth with room to grow
The Raytheon-United Technologies merger in 2020 was the biggest ever in the sector, creating a focused aerospace and defence behemoth from two firms that previously grew both organically and through smaller deals in recent years. Acquisitions included cybersecurity firms Websense and Foreground Security in 2015, Rockwell Collins in 2018, Blue Canyon Technologies, a satellite provider, in 2020 and, in 2021, FlightAware (the world���s largest flight-tracking and data platform) and SEAKR Engineering (a space electronics company).
The post-merger Raytheon reported sales of $64.4bn in 2021, up 13.8% from 2020. The company also achieved an extra $760m of synergies from the merger, taking the total to $1bn. Operating profit was $5bn, but adjusted operating profit (ie, excluding acquisition accounting adjustments) was $7.3bn. Earnings per share (EPS) was $2.6, but $4.3 on an adjusted basis. The company’s guidance for 2022 is for EPS of $4.6 to $4.8 and free cash flow of $6bn, up 20%. The 2025 targets are for a compound annual growth rate in sales of 6%-7%, expanding margins and free cash flow of at least $10bn.
Analysts’ average estimates for EPS are $4.79 for 2022, rising to $5.81 for 2023 and $6.71 for 2024. At the recent price of $103, these EPS figures give a forward price/earnings (p/e) ratio of 21.5 for 2022, falling to 17.7 for 2023 and 15.4 for 2024. However, Raytheon’s guidance was set out in January, before Russia’s invasion of Ukraine. Thus earnings could rise more (and valuations be cheaper) if the general upgrade of Western countries’ defences results in further orders.
Raytheon’s current dividend is $2.04 per share, which gives a reasonable yield of 2%. Share buybacks ($2.3bn in 2021) also support the share price. The first-quarter results are due on 26 April.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Highly qualified (BSc PhD CPhys FInstP MIoD) expert in R&D management, business improvement and investment analysis, Dr Mike Tubbs worked for decades on the 'inside' of corporate giants such as Xerox, Battelle and Lucas. Working in the research and development departments, he learnt what became the key to his investing; knowledge which gave him a unique perspective on the stock markets.
Dr Tubbs went on to create the R&D Scorecard which was presented annually to the Department of Trade & Industry and the European Commission. It was a guide for European businesses on how to improve prospects using correctly applied research and development. He has been a contributor to MoneyWeek for many years, with a particular focus on R&D-driven growth companies.
-
Who won the £1 million jackpot in the May Premium Bonds prize draw?
NS&I has announced the winners of May’s Premium Bonds prize draw. Who won the £1 million jackpot and how can you find out if you scooped a prize this month?
-
Trump's first 100 days: investment winners and losers
Donald Trump triggered a rollercoaster on the stock markets during the first 100 days of his second presidency. We look at which funds, investment trusts and sectors have performed best and worst
-
Three British mid-caps that could make 'attractive' investments
Opinion Charles Luke, manager of the Murray Income Trust, highlights three UK-listed mid-cap companies, as he tells us where he'd put his money
-
Fat profits: should you invest in weight-loss drugs?
The latest weight-loss treatments could transform public health and the world economy. Should you invest?
-
How investors could profit from Ramsden Holdings' four-part growth strategy
Ramsdens Holdings offers a diversified set of financial and retail services and a juicy yield, says Dr Michael Tubbs
-
How to invest in the booming insurance market
The insurance sector is experiencing rapid growth after years of stagnation. Smart investors should buy in now, says Rupert Hargreaves
-
Out of America's shadow: Why Trump's tariff chaos may be good for non-US stocks
Opinion Upending global investment and trade could benefit other countries at the expense of the US market, says Cris Sholto Heaton
-
LendInvest: a promising fintech firm going cheap
Opinion LendInvest has made some mistakes in the past, but it’s now primed for growth, says Rupert Hargreaves
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global markets
Opinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money